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The genome of the human parvovirus B19 contains a transcriptional promoter (BP06) at map position 6,
upstream from the nonstructural protein genes. By cotransfecting HeLa cells with this promoter cloned before
the chloramphenicol acetyltransferase (CAT) gene together with a plasmid containing almost the whole B19
genome, we showed that BPO6 is transactivated by a B19 gene product. The transactivating viral protein was
identified as the nonstructural protein NS-1. NS-1 synthesized in a wheat germ extract specifically stimulates
transcription from BPO6 in vitro. NS-1 of the minute virus of mice (MVM) activates the analogous MVM
promoter, MP04. NS-1, therefore, has a positive feedback effect on the activity of its own promoter. Moreover,
NS-1 ofMVM activates the human BPO6. We have identified, in the genome of B19, a second transcriptional
promoter activity at map position 44, before the capsid protein genes. This promoter, BP44, was identified by
cloning fragments of B19 DNA upstream of the CAT gene, transfecting the DNA into HeLa cells, and
measuring CAT expression. The strength of the BP44 promoter is similar to that of the capsid gene promoter,
MP39, of MVM. In (nonpermissive) HeLa cells, the BP44 promoter is not activated by NS-1. Thus, the BPO6
promoter apparently does not determine the tissue specificity of B19 virus but BP44 could do so.
Autonomous parvoviruses show a strong tropism towards
dividing cells because of their requirement for a cellular
factor expressed during the S phase of the cell cycle. Several
of these viruses are extremely tissue specific, able to grow
only in cells at a particular stage of differentiation (for
reviews, see references 5, 39, and 44).
B19 virus is the first human autonomous parvovirus de-
scribed (8). It is the causal agent of erythema infectiosum, or
fifth disease (1). B19 virus also provokes aplastic crises in
anemics (31, 36), a consequence of the fact that the virus
grows lytically in erythroid progenitor cells at a precisely
defined stage of differentiation (24). Until now, no cell line
permissive for B19 virus growth has been found. The virus is
able to replicate to some extent in cultures of freshly isolated
human bone marrow cells, although permissive cells repre-
sent only a minor portion of these cultures (27). Cotmore and
Tattersall (11) have cloned most of the genome of B19 virus
from a viremic serum, which allowed the determination of
the viral DNA sequence (38). The genomic organization of
B19 virus resembles that of other autonomous parvoviruses
in terms of number and location of open reading frames
(ORFs): there are two large nonoverlapping ORFs, together
occupying a large part of the genome. In addition, two small
ORFs are found in the middle and near the right end of the
viral DNA (10, 38). We and others (6, 17, 26) showed
previously that a transcriptional promoter (BP06) is present
at the left end of the genome of B19 virus; this promoter is
active in vitro as well as in vivo.
In comparison with B19 virus, the autonomous parvovi-
ruses, minute virus of mice (MVM) and the closely related
H-1 virus, have been well studied (for a review, see refer-
ence 43). Two strains of MVM have been isolated: MVMi,
infecting lymphocytes, and MVMp, infecting fibroblasts (2,
42). The DNA sequences of H-1 (30) and of both strains of
MVM (3, 4, 37) have been determined. The genomes of these
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viruses contain two overlapping transcription units (29): one
promoter (MP04) located at 4 map units, directs transcrip-
tion of the genes of the two nonstructural proteins, whose
coding region is situated in the left part of the genome; the
promoter of the second unit (MP39) is located at 39 map
units and is responsible for the transcription of the capsid
protein genes situated on the right part of the genome (12, 20,
34). The MP04 promoter is active earlier in the lytic cycle
than is MP39 (8). Rhode (33) has reported that the nonstruc-
tural protein, NS-1, of H-1 virus is involved in the transac-
tivation of the capsid gene promoter and has identified a
cis-acting element present in this promoter which responds
to NS-1 (35). We have previously shown, by cotransfection
experiments, that in MVMi the nonstructural protein NS-1
(hereafter called MNS-1) stimulates in trans the MP39 pro-
moter (17).
In the work reported here, we investigated the effect of the
nonstructural proteins NS-1 of B19 virus and of MVMi on
the activity of their own promoters, BPO6 and MP04. Unex-
pectedly, we found a positive feedback effect. Until now,
there has been no report of a late promoter upstream of the
capsid protein genes of B19 virus (26). This is surprising,
since other parvoviruses contain such a late promoter (5). By
cloning fragments of B19 viral DNA into plasmid vectors
containing the chloramphenicol acetyltransferase (CAT)
gene, we found evidence for a promoter at map position 44
just before the capsid protein genes of B19 virus.
MATERIALS AND METHODS
T4 DNA polymerase, T4 DNA ligase, restriction en-
zymes, SP6 RNA polymerase, RNase-free DNase, and
RNasin were purchased from Boehringer GmbH, Mann-
heim, Federal Republic of Germany, and were used accord-
ing to Maniatis et al. (22) or the protocol of the supplier.
Plasmid construction. The construction of pMP39-CAT,
pEMBL/i0099 (2), pEMBL/i0052, pMNS-1m, pMNS-2m,
pMNS-2mcapm (17), pEMBL/B19, and pBP06-CAT (16) has
been described elsewhere.
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FIG. 1. Plasmids used in this work. (A) Plasmids containing MVM DNA. The ORF labeled NS-2 is the ORF which is unique to NS-2 and
so can be used to specifically mutate NS-2. The asterisks show mutated sites, and cross-hatched boxes show ORFs no longer read manually
(17). (B) Plasmids containing B19 DNA. Symbols: I, TATA-box-related sequence; C1, pSVO-CAT; 1, pEMBL.
Construction of pMP04-CAT. The TaqI restriction frag-
ment containing the MP04 promoter was isolated from the
clone pEMBL/i0099; one TaqI site is in the polylinker, and
the other one is at position 228, so that the fragment was
about 240 base pairs long. This fragment was blunt ended
with T4 DNA polymerase, ligated to HindlIl linkers, and
inserted into the HindlIl cloning site of pSV0-CAT. Both
orientations were obtained as determined by digestion with
Hinfl (site at position 225).
Construction of pSP6-BNS-l. We inserted the B19 virus
restriction fragments RsaI-HindIII (nucleotides [nt] 333 to
595) and HindIII-PstI (nt 595 to 3145) into a SmaI- and
PstI-cut pSP65 vector in a single trimolecular ligation reac-
tion (see Fig. 3); the RsaI and SmaI blunt ends were ligated
together, allowing the viral HindIII-PstI fragment to insert in
its expected position. Recombinant plasmids were checked
by digestion with restriction enzymes and by transcription
with SP6 RNA polymerase of the plasmid linearized with
different restriction enzymes.
Construction of pBP44-CAT. We isolated the SmaI-
TthlllI fragment (nt 2073 to 2277) from pEMBL/B19, made
it blunt with T4 DNA polymerase, ligated it to 8-mer HindIll
linkers, and inserted it into the HindIII cloning site of the
plasmid pSV0-CAT. Both orientations were obtained, as
determined by digestion of the recombinant plasmid with
Avall (position 2075). The other B19-CAT plasmids (Fig. 1)
were constructed by similar methods.
Construction of pBl9-capm. This clone was constructed by
digestion of pEMBL/B19 with PstI, followed by isolation of
the larger fragment (containing the vector [14] and the larger
viral PstI fragment, from nt 1 to 3145) and subsequent
religation.
Transfection of HeLa and EL-4 cells and CAT assays. HeLa
or EL-4 cells were plated on 6-cm petri dishes (6 x 105 cells
per plate) 24 h before transfection. The DNA (purified by a
CsCl-ethidium bromide gradient) was transfected into HeLa
cells by the calcium phosphate method of Graham and Van
der Eb (19) and into EL-4 cells by the DEAE-dextran
method of Sompayrac and Danna (40). At 48 h after trans-
fection, the cells were washed, harvested, suspended in 100
,u of 250 mM Tris hydrochloride, pH 7.5, and lysed by three
cycles of freezing and thawing. The cell debris was removed
by centrifugation, and the supernatant was heated for 5 min
at 65°C. This step greatly enhances the CAT activity of a
given extract, presumably by inactivating a inhibitor or a
deacetylating activity present in the extract. The assay
mixture (18) contained 20 RI of cell extract, 19 RI of 250 mM
Tris hydrochloride (pH 7.5), 1 ,ul of '4C-labeled chloram-
phenicol (0.2 mCi/ml, 54 mCi/mmol; Amersham Interna-
tional, United Kingdom) and 5 ,ul of 44 mM acetylcoenzyme
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A. The reaction was carried out at 37°C for 14 h and stopped
by addition of 0.5 ml of ethylacetate, which was also used to
extract the chloramphenicol and its acetylated derivatives.
(Control experiments showed that the 14-h incubation gave
qualitatively the same results as a 1-h incubation, but with
greater sensitivity.) The organic layer was lyophilized, and
the chloramphenicol was taken up in 30 pul of ethylacetate,
spotted on silica gel thin-layer plates, and chromatographed
with chloroform-methanol (95:1). The plate was then dried
and exposed to film (Kodak X-AR5) for autoradiography.
Transcription in vitro with SP6 RNA polymerase and trans-
lation in vitro with wheat germ extract. We have slightly
modified the method of Struhl and Hope (41), which derives
from that of Melton et al. (21, 23). One microgram of
template DNA (SP6-BNS-1 linearized with PstI) was tran-
scribed in a reaction (25 p,l) containing 40 mM Tris hydro-
chloride (pH 8.0), 6 mM MgCl2, 2 mM spermidine, 10 mM
NaCl, 100 p,g of bovine serum albumin, 1 mM dithiothreitol,
1 U of RNasin per pul, 500 puM ATP, CTP, and UTP, 500 puM
diGTP (3'OH-G-ppp-G-3'OH) (Pharmacia, Inc.), 50 puM
GTP, and 200 to 500 U of SP6 RNA polymerase per ml. The
diGTP is an analog of the cap structure, and its presence
during the transcription improves the ability of the RNA to
be translated (41). After 45 to 60 min at 40°C, we added 450
p.M GTP and let the reaction go on for another 30 to 45 min.
The DNA template was then digested by addition of RNase-
free DNase 1 (400 U/ml) during 20 min at 37°C. After phenol
extraction, the RNA (about 10 ,ug according to approximate
quantitation by ethidium bromide staining) was precipitated
with ethanol.
The RNA was dissolved in water, and one-third of it
(about 3 ,ug) was added to a 100-Rd translation reaction
containing 50 RI1 of wheat germ extract (Amersham), 100 ,uM
amino acids minus Met, 1 ,uCi of [35S]Met (>800 Ci/mmol, 15
mCi/ml) per ,ul 500 U of RNasin per ml, and 72 mM
CH3COOK (72 mM is the optimal K+ concentration we
determined for a maximal incorporation of [35S]Met into
protein; this optimal concentration depends on the mRNA
used as a template). As a negative control, we did the same
reaction but added water without RNA. Incorporated radio-
activity was measured by incubation of a portion at 37°C in
50 mM NaOH (to hydrolyze amino-acyl-tRNA) followed by
trichloroacetic acid precipitation, washing on glass fiber
filters, and counting in a scintillation counter.
NS-1 was immunoprecipitated from in vitro translation
mixtures by using rabbit antiserum prepared against a bac-
terially produced trpE-NS-1 fusion protein (F. Beutler and
C. Doerig, unpublished data). Antiserum and the solution
containing NS-1 were mixed at 4°C for 2 h, one-half volume
of protein A-Sepharose beads (Pharmacia) was added, and
the incubation was continued for 1 h. The beads were
collected by centrifugation, and washed three times with a
solution of 10 mM Tris hydrochloride (pH 8), 1 mM EDTA,
and 100 mM NaCl, and then suspended in sample buffer for
polyacrylamide gel electrophoresis.
Transcription in vitro with HeLa cell extracts. HeLa nu-
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2 3 4 5 7 R capsid gene promoter by NS-1 of autonomous parvoviruses
is well established (16, 31, 32). We asked whether the NS-1
protein of MVMi (that is MNS-1) also controls the activity of
its own promoter, MP04.
1 4MW#*i We constructed a reporter plasmid (pMP04-CAT) in which
the CAT gene was under the control of the MP04 promoter.
When we tested the ability of this plasmid to express CAT
upon transfection into EL-4 cells, we observed that only the
clone in which the viral fragment was in the right orientation
relative to the CAT gene (i.e., with the TaqI site at position
228 proximal to the CAT gene) expressed CAT (see Fig. 2)
and not the clone in which the viral fragment was inserted in
the opposite orientation (not shown). Thus, the MP04 pro-
moter was functional in our reporter plasmid. We then tested
Ij * * * * * 41 4^ whether a clone (pEMBL/i0099) (2, 17) containing the whole
MVMi genome (except a part of the 5' palindrome) ex-
pressed a product that would activate in trans the production
of CAT from pMP04-CAT. If a viral gene product expressed
from the genomic clone is able to activate transcription from
**Jt4 ^ a viral promoter controlling the transcription of the CAT
gene, we should observe increased CAT activity in cells
+-n r containing both plasmids compared with cells containing
r8SCD)CCl only the CAT construct. EL-4 cells were transfected with a
01:5 CD. em, u? Q mixture of pMP04-CAT and pEMBL/i0099, and the CAT
0. , JX z E activity was measured in cell extracts. It is clear from Fig. 2
co C E e:,ithat the CAT activity was higher in cells transfected with
_ 2 2 <both plasmids (lane 4) than in cells transfected with pMP04-0.3:> a <;CAT alone (lane 3). There was about five times more
acetylated chloramphenicol in lane 4 of Fig. 2 than in lane 3,
as determined by scintillation counting.pMPO4-CAT cotr-ans .. Cil Wfl't To determine which of the viral proteins was responsible
FIG. 2. Transactivation of the MP04 promoter by NS-1 in trans- for this transactivation, we performed similar experiments in
fected EL-4 cells. EL-4 cells were transfected with 0.5 p.g of which the plasmid cotransfected with pMP04-CAT was from
pMP04-CAT and 0.5,ug of the indicated plasmids per 6-cm petri dish a series of clones able to express subsets of viral proteins.
by the DEAE-dextran method (17). At 48 h posttransfection, we The structure of these plasmids and how they were made has
prepared cell extracts and measured the CAT activity, using 14C- already been described (17). When the plasmid cotransfected
labeled chloramphenicol as a substrate (17). The acetylated and the with pMP04-CAT was pEMBL/i0052, which lacks most of
unacetylated forms of chloramphenicol were separated by thin-layer the capsid protein-coding sequences, the CAT activity (Fig.
chromatography and localized by autoradiography. The controls 2 lane 5) was again higher than in cells transfected with
were cells transfected with S ,ug of pRSV-CAT (lane 1) and cells 2, aln (Fg. than In This indicted thtransfected with 5 ig of promoterless pSVO-CAT (lane 2) (17). Other pMPo4-CAT alone (Fig. 2, lane 3). This indicated that alanes indicate pMP04-CAT cotransfected with no plasmid (lane 3), nonstructural protein transactivates the MPO4 promoter. To
pEMBL/iOO99 (lane 4), pEMBL/i0052 (lane 5), pMNS-2m (lane 6), determine which nonstructural protein, we cotransfected
pMNS-lm (lane 7), and pMNS-2mcapm (lane 8). pMP04-CAT with either pMNS-lm or pMNS-2m. These
plasmids are unable to express intact either MNS-1 or
clear extracts were made by the procedure of Dignam et al. MNS-2, respectively (17). We observed that pMNS-2m was
(15). The transcription reaction (50 RIu) contained 0.2 to 1 ,ug able to transactivate CAT expression from pMP04-CAT to a
of DNA template, 200 ,uM ATP, GTP, and CTP, 20 ,uM level equivalent to that produced by cotransfection of
UTP, 10 ,Ci of [32P]UTP (400 Ci/mmol), 5 mM creatine pMP04-CAT and pEMBL/i0099 (Fig. 2, lanes 4 and 6).
phosphate, 0.1 ,ug of poly(dIC), and 25 ,il of HeLa nuclear pMNS-lm, on the other hand, had no effect on the expres-
extract; portions from in vitro translation reactions were sion of CAT from pMP04-CAT (Fig. 2, lane 7). Thus, NS-1
added as described in the text. The reaction was carried out seems to be necessary for the transactivation of MP04. The
at 30°C for 1 h, and the nucleic acids were then purified by clone pMNS-2m which expresses NS-1 (and the domain of
digestion with pronase (0.1 ,ug/ml) for 20 min at 37°C in the NS-2 which is shared with NS-1) transactivates MP04 as
presence of 1% sodium dodecyl sulfate extraction with efficiently as does the whole MVMi genome. We noted that
phenol, addition of 10 ,g of carrier tRNA, and ethanol the CAT activity was somewhat lower when transactivation
precipitation. They were redissolved in water and denatured was by pEMBL/i0052 (Fig. 2, lane 5) rather than by the
by glyoxal (15 min at 50°C in the presence of 2 volumes of whole viral genome (Fig. 2, lane 4). Two interpretations are
75% dimethyl sulfoxide, 15 mM NaPO4 [pH 6.9], 0.15% possible: either the capsid proteins are needed in conjunc-
sodium dodecyl sulfate, and 7% glyoxal). Electrophoresis tion with MNS-1 for a maximum level of transactivation or
was carried out in a 1.8% agarose gel in 10 mM NaPO4, pH the lack of the polyadenylation site for the MNS-1 mRNA in
6.9. The gel was then dried and exposed to a Kodak X-AR5 pEMBL/i0052 leads to a reduced expression of MNS-1. To
film for autoradiography. distinguish these two possibilities, we measured transactiva-
RESULTS tion by the plasmid pMNS-2mcapm, which contains theRESULTS polyadenylation site and is able to express MNS-1 but
Transactivation of the early promoter MP04 of MVM by neither MNS-2 nor the capsid proteins (17). We observed
NS-1 in transfected EL-4 cells. The transactivation of the (Fig. 2, lane 8) that this plasmid stimulated, to the same
J. VIROL.
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FIG. 3. Transactivation of B19 virus and MVM promoters by
virus-coded proteins in transfected HeLa cells. CAT assays were as
described in the legend to Fig. 2. The promoter-containing plasmids
tested were pMP04-CAT (0.5 ,ug) (lanes 1 through 5), pMP39-CAT (1
,ug) (lanes 6 through 8), and pBP06-CAT (0.5 ,ug) (lanes 9 through
13). The transactivating plasmids are indicated: none in lanes 1, 6,
and 9; pMNS-2mcapm, 0.5 ,ug in lanes 2 and 12 and 1 ,ug in lanes 3,
7, and 13; pB19capm, 0.5 ,ug in lane 4 and 1 ,ug in lanes 5 and 8;
pEMBL/B19, 0.5 ,ug in lane 10 and 1 ,ug in lane 11.
extent as pEMBL/i0099, the production of CAT from
pMP04-CAT. This result argues against an involvement of
the capsid proteins in transactivation of the MP04 promoter
in this experiment. Our interpretation of these results is that
NS-1 has a positive feedback effect on the MP04 promoter,
in addition to its known ability to transactivate the MP39
promoter.
The BPO6 promoter is transactivated by a B19-encoded gene
product in transfected HeLa cells. Since expression from both
viral promoters of MVMi is activated in trans by MNS-1, we
asked whether transactivation of expression from the pro-
moter BPO6 (6, 16) of the human parvovirus B19 by a B19
virus-encoded gene product occurs. We constructed a plas-
mid, pBP06-CAT (16), with the BP06 promoter linked to the
bacterial CAT gene. We performed cotransfection experi-
ments in which the plasmid pBP06-CAT was transfected into
HeLa cells together with the plasmid pEMBL/B19. This
latter clone (16) derives from the plasmid pYT103 described
by Cotmore and Tattersall (11) and contains almost the
complete genome of B19 virus (minus a part of the terminal
hairpin structures).
Figure 3, lanes 9 through 11 show that the BPO6 promoter
is activated in trans by a B19 gene product; this transacti-
vation is similar in strength to that ofMP04 by MNS-1 (lanes
1 through 3). By analogy to MVM, the protein responsible
for the transactivation of the BPO6 promoter might be
expected to be BNS-1. To test this hypothesis and to check
in a more direct way the effect of BNS-1 on the activity of
the BPO6 promoter, we synthesized BNS-1 in vitro and
tested the ability of this protein to modulate transcription
from the BPO6 promoter in vitro.
In vitro synthesis of BNS-1. We obtained BNS-1 in vitro by
translating in a cell extract the RNA synthesized by the SP6
RNA polymerase from the plasmid pSP6-BNS-1 (Fig. 4A).
Transcripts produced by SP6 RNA polymerase with this
plasmid used as a template are shown in Fig. 4B. We
linearized the plasmid template with PstI and used the runoff
transcripts synthesized (containing the whole BNS-1 coding
region) as a template for cell-free translation in a wheat germ
extract (Fig. 4C). The protein produced had the expected
apparent molecular mass as deduced from the DNA se-
quence (38), about 72 kilodaltons (Fig. 4C, lane 4). The
strong band at 68 kilodaltons, corresponding presumably to
premature termination of translation, has also been detected
in in vitro translation experiments using mRNA extracted
from B19-infected bone marrow cells (17, 28). The bands of
lower molecular mass were probably also products of pre-
mature translation termination, since they were absent in
reaction mixtures containing no exogenous mRNA (data not
shown). The full-length protein and the lower-molecular-
mass bands were immunoprecipitable with an anti-BNS-1
antiserum raised against a fusion protein containing the
carboxy-terminal part of BNS-1 (Fig. 4C, lanes 2 and 3) but
not with a preimmune serum (Fig. 4C, lane 1). We conclude
from these results that the protein we synthesized in vitro
was BNS-1.
BNS-1 synthesized in vitro stimulates transcription from the
BPO6 promoter in vitro. To determine whether the BNS-1
protein synthesized in vitro had an effect on the activity of
B19 promoters, we performed in vitro transcription assays in
HeLa cell nuclear extracts, using restriction fragments of
B19 DNA as templates. Portions of translation reaction
mixtures with either BNS-1 mRNA or no exogenous mRNA
(and therefore containing or not the BNS-1 protein) were
added to transcription reactions, and the yield of runoff
transcripts were compared. The presence or absence of
BNS-1 was the only difference between these two transcrip-
tion reactions, since the same volume of in vitro translation
mixture was added to each. Figure 5, lanes 1 and 2, show the
runoff transcripts generated from the B19 virus PstI A
fragment in the absence (lane 1) or in the presence (lane 2) of
the in vitro-synthesized BNS-1 protein. In the presence of
BNS-1, the increase in the quantity of the transcript of 2.8
kilobases originating at the BPO6 promoter (16) was clear.
The intensity of the nonspecific bands did not vary signifi-
cantly between the two lanes. (The nonspecific bands were
possibly due to either end labeling of endogenous RNA
molecules present in the extract or to transcripts originating
in the vector DNA). To make sure the increase in the
intensity of the 2.8-kilobase band was not due to the labeling
of the pSP6-BNS-1-derived mRNA which was used as a
template for the synthesis of BNS-1 (and which has a size
near that of the runoff transcript), we repeated the experi-
ment, using the BamHI A fragment as a template for in vitro
transcription. This fragment yields a transcript of about 3.4
kilobases when RNA synthesis is initiated at the BPO6
promoter (16). As can be seen in lanes 3 and 4 of Fig. 5, the
addition of a portion from a translation reaction mixture
containing BNS-1 also increased the yield of transcripts from
the BamHI A fragment. Therefore, the increase in labeled
RNA we detected in the presence of BNS-1 reflects a
stimulation of transcription of the restriction fragment tem-
plate. When, in parallel reactions, we tested the effect of
BNS-1 on the activity of the simian virus 40 early promoter
(Fig. 5, lanes 5 and 6), we observed no increase but rather a
slight decrease in the quantity of simian virus 40 transcripts
(about 2 kilobases) in the presence of BNS-1. The effect we
observed on the BPO6 promoter was, therefore, not due to a
nonspecific enhancement of the transcriptional activity in
the HeLa extract by BNS-1. We conclude from these results
that BNS-1 is able to transactivate the BPO6 promoter in
vitro.
The NS-1 proteins of both B19 virus and MVMi are able to
activate both BPO6 and MP04. Can the NS-1 protein of one
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FIG. 4. In vitro synthesis of the NS-1 protein of B19 virus. (A) Structure of plasmid pSP6-BNS-1. The runoff RNAs expected on
transcription of the plasmid linearized with AccI or PstI by SP6 RNA polymerase are shown. (B) Runoff RNAs made by SP6 RNA
polymerase. The pSP6-BNS-1 template was linearized with AccI (lane 1) or PstI (lane 2). RNAs were reacted with glyoxal (described in
Materials and Methods), electrophoresed in an agarose gel, and stained with ethidium bromide. Sizes of bands (in kilobases) are indicated on
the right. (C) 35S-labeled proteins made in vitro from SP6 RNA polymerase-synthesized in BNS-1 mRNA. Proteins were made in a wheat germ
extract and immunoprecipitated by preimmune serum (lane 1) or anti-BNS-1 sera (lanes 2 and 3) or the translation reaction mixture was
analyzed without immunoprecipitation (lane 4). Molecular size markers are indicated in lane 5, and sizes are given in kilodaltons on the left.
Proteins were electrophoresed in a polyacrylamide gel and detected by autoradiography.
parvovirus activate transcription from the other? To answer
this question, we first performed cotransfections of HeLa
cells by using pBP06-CAT and pMNS-2mcapm; this latter
plasmid is a modified MVMi clone able to express only
MNS-1 (17). In Fig. 3, lanes 9 through 13 show that MNS-1
is able to activate expression from the BPO6 promoter with
the same efficiency as BNS-1. We also tested the symmet-
rical combination and cotransfected pMP04-CAT together
with pB19capm, a clone containing the left part of B19 virus
genome, from the left end to the PstI site at position 3145
(Fig. 1). The result (Fig. 3, lanes 1 through 5) shows that B19
virus nonstructural protein activates expression from the
MP04 promoter but to a lesser extent than MNS-1 does.
Such a cross-transactivation was not observed with the
capsid gene promoter MP39: this promoter was activated by
pMNS-2mcapm but not by pB19capm (Fig. 3, lanes 6 through
8).
Promoter activity at 44 map units on the genome of the B19
virus in transfected HeLa cells. The existence in B19 virus of
a promoter (BP06) near the left end of the genome is a
feature shared by all the autonomous parvoviruses studied
so far. The other parvoviruses, but not B19 (26), have been
shown to have a second promoter located near the middle of
the genome (at 39 map units in the case ofMVM) controlling
the transcription of the capsid protein genes. Since the
genome of B19 virus contains TATA-box-related sequences
at map positions 44 and 45 (38), we decided to determine
whether or not a DNA fragment carrying one or both of
these TATA boxes was able to promote transcription in
vivo. For this purpose, we constructed a series of plasmids
in which the gene for the bacterial enzyme CAT was placed
downstream of these TATA boxes (Fig. 1), transfected them
into HeLa cells, and measured the CAT activity in the
transfected cells. The cells transfected with plasmids con-
taining both TATA elements did not produce any CAT
activity above the background level (data not shown); on the
other hand, the plasmid pBP44-CAT, containing the viral
fragment SmaI-TthlllI (nt 2071 through 2247), induced the
expression of CAT (Fig. 6, lane 6). The same fragment
inserted in the opposite orientation relative to the CAT gene
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FIG. 5. Effect of adding BNS-1 protein synthesized in vitro on
transcription. In vitro transcription reactions contained as template
pEMBL/B19 digested by PstI (lanes 1 and 2) or by BamHI (lanes 3
and 4) or simian virus 40 DNA digested by PstI (lanes 5 and 6).
BamHI cuts B19 viral DNA at position 3896, and PstI cuts at
positions 3145 and 3860. The transcription reactions (50 ,ul) included
3 p.l of in vitro translation mix either with (lanes 2, 4, and 6) or
without (lanes 1, 3, and 5) pSP6-BNS-1 RNA. Sizes of bands (in
kilobases) are indicated on the left; the runoff transcript bands of
interest are indicated by the arrows on the right. Size markers were
Hinfi-digested simian virus 40 DNA and HindIII-digested X DNA.
did not lead to the production of CAT (Fig. 6, lane 1). By
transfecting various amounts of DNA, the strength of the
promoter activity in pBP44-CAT was compared with that in
pMP39-CAT (a plasmid in which the CAT gene is under the
control of the MP39 promoter of MVMi [17]). The two
promoters had very similar activities (Fig. 6, compare lanes
2 through 4 with lanes 6 through 8, respectively).
The basal activity of the BP44 promoter in pBP44-CAT
was not increased when the HeLa cells were cotransfected
with pEMBL/B19 containing almost all the B19 genome (Fig.
6, lane 9). The BP44 promoter in plasmid pBP44HT-CAT
which contains a longer stretch of upstream sequence (Fig.
1) was likewise not transactivated (data not shown). The
MP39 promoter of MVM, on the other hand, was transacti-
vated by cotransfection with the equivalent MVM clone,
pEMBL/i0099 (Fig. 6, lane 5; 17). MP39 was not activated by
NS-1 of B19 virus nor was BP44 activated by MNS-1 (Fig. 3,
lane 8; results not shown).
DISCUSSION
Positive feedback regulation of the early promoter of auton-
omous parvoviruses. The conclusion that the NS-1 protein of
autonomous parvoviruses has a positive feedback effect on
the activity of its own promoter is based on several indepen-
dent lines of evidence. Firstly, cells transfected with this
promoter of B19 virus or MVM linked to the CAT gene
produced more CAT activity when cotransfected with a
6 7 8 9
FIG. 6. The activities of promoters MP39 and MP44 in HeLa
cells. The transfected plasmids (and amounts) were the following:
pBP44-CATw" (15 ,ug [lane 1]; this plasmid has the promoter
sequence inserted in the wrong orientation); pMP39-CAT (10 ,ug;
[lane 2]; 5 ,ug [lane 3] and 1 ,ug [lanes 4 and 5]); pEMBL/10099 (1 ,ug)
was cotransfected in lane 5; pBP44-CAT (10 ,ug [lane 6], 5 ,ug [lane
7], and 1 ,ug [lanes 8 and 9]); and pEMBL/B19 (1 ,ug) was also
cotransfected in lane 9. CAT assays were as described in the legend
for Fig. 2.
plasmid expressing NS-1. Regulation of CAT expression
could occur at various levels (43). Secondly, the amount of
mRNA transcribed from the MP04 promoter is lower in
transfected cells containing a mutated NS-1 protein than in
cells containing the wild-type NS-1 (17). Thirdly, NS-1 of
B19 virus synthesized in vitro activates transcription from
BPO6 in vitro. The same result has been obtained with MVM
NS-1 and the promoter MP04 (unpublished results).
Rhode and Richard (35) characterized a cis-acting element
in the P38 promoter of H-1 virus which responds to NS-1
(H-1 is a virus closely related to MVM). They reported that
the minimal sequence required for transactivation is a se-
quence of 13 base pairs, named tar, located between posi-
tions -138 and -126 relative to the start site of the capsid
gene mRNA. The MP39 promoter of MVMi has an almost
identical sequence between positions 1868 and 1880 (that is,
from -139 to -127 relative to the cap site of the capsid
mRNA; see Fig. 7). This is not surprising, since the viruses
are related. A DNA sequence related to the central core
portion of the tar element, TGGTTGGT, is present unex-
pectedly often throughout the MVM genome (7). The func-
tion of this sequence is not yet clear. Nevertheless, what is
interesting in view of our finding that MP04 is also activated
by NS-1 is that upstream of the MP04 promoter, between
map positions 96 and 105 (-107 to -95 from the nonstruc-
tural protein mRNA cap site), is a sequence with high
homology to a longer stretch of the tar present in the MP39
promoter (Fig. 7). This sequence, CNTGGTTGGTNAA,
occurs at only these two places in the MVMi genome. The
function of these sequences in MVMi has not yet been
tested, but, although it is not proven, we suspect that they
share the same functional properties as the H-1 P38 tar.
Contradictory results have been reported previously for
the effect of NS proteins on early promoter function. It has
been stated (35) that NS-1 of the H-1 parvovirus inhibits
rather than stimulates the activity of the P04 promoter. Since
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A.
H-i P38 tar tgtg CTTGGTTGGTGAA gaat
**** ********** ** ****
MVMi P39 tgtg CTTGGTTGGTAAA gaat
* ******** * *
MVMi P04 ctca CATGGTTGGTCAG ttct
265
-138 to -126
-139 to -127
-107 to - 95
284 319
tattg GTTAGTT ttgtaacg-------TATAT
* ******* *
gaact GTTAGTT ggggttga-------TATTA
2180 2199 2249
actataattttattgGTTAGTTttgtaacggttaa
* * * ****** ** * * * *
catgatttgtgCTTGGTTGGTAAAgaatggttacc
* ***g***** ** * *
tttcgtgaactGTTAGTTggggttgattatgtgtg
-73 to -79
-88 to -94
FIG. 7. Comparison of the tar element of the H-1 virus P38 promoter with the related sequence elements of the MVMi P39 and P04
promoters and B19 virus P44 and P06 promoters. Homology between two bases is indicated by an asterisk. (A) Sequences in MVM. The 13
bases of the tar elements are shown in capital letters, and their positions relative to the RNA start site are indicated on the right. The H-1
virus P04 tar is identical to the MVMi P04 tar (34). (B) Related sequence elements upstream from B19 virus promoters. The numbers above
and below the sequences show nucleotide positions in the B19 viral DNA sequence. The positions (shown on the right) of the related
sequences relative to the RNA start sites are estimated from the positions of the TATA boxes, since the exact start sites have not been
determined. (C) Comparison of B19 virus and MVMi sequences.
H-1 and MVMi are so similar, and since a tar identical to the
tar of the P04 promoter of MVMi is present upstream of the
P04 promoter of H-1 (34), we should expect the NS-1 of H-1
virus to stimulate P04, as we have found with MVMi. Details
of the H-1 virus experiment (35) were not given, although
cell lines different from those in the present work were used.
On the other hand, the NS protein of B19 virus was reported
not to suppress transcription from the BPO6 promoter (25).
We suggest that, as these early promoters are relatively
strong, the amount of CAT gene-containing test plasmid
added to the cells may have been such that the basal level of
CAT expression was already high, so the subsequent trans-
activation that we observed was not measurable.
Why should NS-1 activate its own promoter, while other
viral regulatory proteins (for example, the T antigen of
simian virus 40 (32) or ICP4 of herpes simplex virus [30]),
repress theirs? The reason might be that NS-1, unlike these
other viral regulatory proteins, is also a component of the
virus particle: NS-1 ofMVM is attached to the 5' end of viral
DNA (13). NS-1 would be needed, towards the end of the
lytic cycle, for incorporation into viral progeny.
Transcriptional promoter activity at map position 44 on the
genome of B19 virus. Evidence for a transcriptional promoter
activity at map position 44 on the B19 virus genome comes
from the fact that the SmaI-TthillI fragment (nt 2073 to
2277) promoted expression of the CAT gene in transfected
HeLa cells. The promoter activity was lost if the viral DNA
fragment was inserted in the opposite orientation. The level
of CAT activity in cells transfected with pBP44-CAT was
similar to that in cells transfected with pMP39-CAT. A
TATA-box-related sequence (TATTAA) is found between
positions 2247 and 2251, that is about 30 base pairs upstream
of the TthlllI site. CAT constructs containing restriction
fragments extending further to the right (for example, to the
TaqI site at position 2326 or the HindIII site at position 2430)
did not promote CAT activity, possibly because the longer
distance between the promoter and the CAT gene allowed
initiation of translation at a wrong AUG codon. The position
of the BP44 promoter relative to the beginning of the ORF of
the capsid protein gene makes use of this promoter for the
initiation of capsid mRNA synthesis possible. The distance
between the two (positions 2250 and 2670) is about 420 nt,
and in MVMi, in which the role of the MP39 promoter in the
transcription of the capsid protein gene is well documented,
the distance between these elements is 320 base pairs.
A feature shared by the early and late promoters ofMVM
and H-1 virus is the presence of the tar sequence, about 100
base pairs upstream from the TATA boxes (discussed earli-
er). This is also true of the two promoters which we have
detected in B19 virus (Fig. 7A): an identical sequence of 7 nt
lies upstream of the TATA box of the BPO6 and BP44
promoters; this sequence occurs nowhere else in the B19
virus genome. Moreover, the sequence is homologous to the
tar elements ofMVM; in B19 virus, it is slightly closer to the
RNA start site than the tar sequence is to the RNA start site
in MVM (Fig. 7A and B). The roles that these elements in
B19 virus promoters may play in the regulation of viral
transcription remain, as with MVM, to be demonstrated
experimentally. Nevertheless, our results show that there
are many similarities between the BP44 promoter and the
MP39 promoter: at the structural level, they are located a
similar distance upstream of the capsid protein ORF (and
within the coding region of the NS-1 gene). They contain a
sequence element which is also present in the promoter
controlling the transcription of the nonstructural protein
genes; this element resembles the tar which has been shown
in H-1 virus to play a role in the regulation of transcription
by NS-1. At the functional level, both promoters have a
similar activity in transfected HeLa cells. Thus, we believe
that the internal promoter activity in B19 virus could be
responsible for transcription of capsid protein genes, as it is
in other parvoviruses.
A promoter located near the middle of the genome of B19
virus was also reported by Deiss et al. (V. Deiss, J.
Tratschlin, and G. Siegl, 2nd Parvovirus Workshop Ab-
stracts, Oxford, U.K., p. 21, 1987), who used a similar
B.
B19 P06
B19 P44
C.
B19 P06
MVMi P39
B19 P44
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approach to that described in this report. However, Osawa
et al. (26) proposed a transcriptional map for B19 virus in
which all of the viral transcripts are initiated at the BPO6
promoter. Their data were obtained by successive hybrid-
ization of filter-bound RNA from cultured bone marrow cells
infected with B19 virus with several labeled viral DNA
fragments. They found evidence for nine viral transcripts
generated from the BPO6 promoter; some transcripts had a
structure unable to code for any polypeptide. Osawa et al.
(26) also looked for a late promoter within the B19 virus
genome by linking B19 virus DNA fragments to the CAT
gene. They did not find the promoter we detected (at map
position 44) because they looked only as far as map position
38.
Our results show that the BP(6, but not the BP44 pro-
moter, is transactivated by BNS-1 in nonpermissive cells. As
pointed out elsewhere (27), the permissive cells represent
only a minor fraction of the cells present in the bone marrow
cell cultures. Thus, it is possible that the viral transcripts
originating from BPO6 only, as detected by Osawa et al. (26),
are produced mainly during the abortive infection of the
nonpermissive cells present in large excess over the permis-
sive cells in the bone marrow culture. The uninduced activ-
ities of BP44 and MP39, although easily detectable in CAT
assays, are low. We have not been able, with an RNase
protection assay, to detect RNA generated from the BP44
promoter in HeLa cells transfected with pEMBL/B19. This
is not surprising, since, with the same assay, we also did not
detect the mRNAs for MVM capsid proteins in the absence
of transactivation of MP39 (17; data not shown).
Control of transcription in B19 virus. We have shown that
transactivation by NS-1 of the promoter controlling tran-
scription of the nonstructural protein genes occurs in B19
virus as well as in MVM. The fact that in HeLa cells the
promoters BP06 and MP04 respond to BNS-1 and MNS-1
indicates that these proteins are functionally closely related
and that transactivation of these promoters is not, appar-
ently, a cell-type-specific process. The main difference we
have observed in the transcriptional organization of these
viruses is that in HeLa cells the capsid protein gene pro-
moter of MVM (MP39) is strongly transactivated by MNS-1
(17), whereas the analogous promoter activity (BP44) of B19
is not stimulated by BNS-1. Perhaps there is no transactiva-
tion of the BP44 promoter by NS-1 in transfected HeLa cells
because these cells lack an additional factor needed for
efficient use of this promoter. Transactivation may occur in
other types of cells able to support a productive infection.
The tissue specificity of B19 virus may be thus related to
regulation of viral transcription.
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